Showing results (431-440 of 928) with videos related to
Sort By:
Pageof 93
International Clinical Psychopharmacology|February 1, 2011
Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRIStella Bitran, Amy H Farabaugh, Victoria E Ameral, et al.Journal of Psychopharmacology (Oxford, England)|March 8, 2019
Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept studyJoseph Biederman, Annika Lindsten, Lasse B Sluth, et al.The Journal of Clinical Psychiatry|January 14, 2003
An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analysesJohn D Matthews, Kathryn A Bottonari, Laura M Polania, et al.Depression and Anxiety|October 12, 2013
Clinical relevance of fatigue as a residual symptom in major depressive disorderMaurizio Fava, Susan Ball, J Craig Nelson, et al.Archives of General Psychiatry|December 8, 2010
Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorderRoy H Perlis, Rudolf Uher, Michael Ostacher, et al.The Journal of Clinical Psychiatry|November 8, 2011
Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study GroupJustin A Chen, George I Papakostas, Soo Jeong Youn, et al.Schizophrenia Research|April 22, 2021
Relationship between cannabis use and psychotic experiences in college studentsAbigail C Wright, Corinne Cather, Amy Farabaugh, et al.Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 30, 2020
NSI-189 phosphate, a novel neurogenic compound, selectively benefits moderately depressed patients: A post-hoc analysis of a phase 2 study of major depressive disorderKarl K Johe, Gary Kay, Santosh Kumar, et al.Primary Health Care : Open Access|February 14, 2014
Using the Electronic Medical Record to Examine Racial and Ethnic Differences in Depression Diagnosis and Treatment in a Primary Care PopulationNhi-Ha T Trinh, Rachel Larocca, Susan Regan, et al.The Journal of Clinical Psychiatry|March 29, 2006
Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trialMaurizio Fava, H George Nurnberg, Stuart N Seidman, et al.Pageof 93